Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) 0.00
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio N/A
Volume 831,900
Avg Vol 567,634
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K 62%
Beta N/A
Analysts Strong Buy
Price Target N/A
FAITH2026
FAITH2026 Jun. 29 at 3:29 PM
$TRLV You would think that with the ALJ Hearings starting today, that the Cannabis Sector would show some signs of life. Maybe the retail investor has just been burned way too many times before with "buy the rumor, sell the news".
2 · Reply
tutster
tutster Jun. 29 at 3:01 PM
$HITI Europe: More Than Just Germany Many investors still view Remexian as a German acquisition. I don't. Since acquiring Remexian, High Tide has: 🟢 Increased German medical cannabis market share from ~5% to ~14% 🟢 Successfully resolved major procurement challenges 🟢 Recovered gross margins to 27% 🟢 Secured exclusive supply agreements with leading Canadian LPs 🟢 Established itself as one of Germany's leading medical cannabis distributors Germany is already Europe's largest medical cannabis market. Management has repeatedly highlighted the UK as its next strategic opportunity, with independent forecasts projecting a medical cannabis market of ~£900M by 2030. France, Poland and other European markets are gradually opening as well. To me, High Tide didn't buy Germany. It bought a gateway into Europe. $HITI $MSOS $GTBIF $TRLV
0 · Reply
thepalace2007
thepalace2007 Jun. 29 at 1:57 PM
$TRLV this will be $20+ very soon
0 · Reply
tutster
tutster Jun. 29 at 12:32 PM
$HITI Procurement: The Most Overlooked Competitive Advantage? Most investors compare cannabis companies by: • Revenue • EBITDA • Store count But mature industries often reward something else. 🟢 Costco didn't become successful because it produced food. 🟢 Walmart doesn't manufacture consumer goods. 🟢 McKesson doesn't invent pharmaceuticals. They control purchasing power. The larger the purchasing volume... 🟢 the better the prices 🟢 the stronger the supplier relationships 🟢 the greater the product selection 🟢 the higher the potential margin Raj Grover rarely talks about becoming the largest grower. Instead, he repeatedly talks about procurement and building the largest cannabis menu. Could procurement become one of High Tide's biggest competitive advantages? Next: Why Europe could be much bigger than most investors expect. $HITI $MSOS $GTBIF $TRLV
2 · Reply
tutster
tutster Jun. 29 at 12:17 PM
$HITI Follow The Money One of the best ways to understand a company is to ignore what management says... ...and look at where they allocate capital. Over the past few years, Raj Grover acquired: 🟢 Smoke Cartel 🟢 Daily High Club 🟢 NuLeaf Naturals 🟢 FAB CBD 🟢 DankStop 🟢 Remexian Now ask yourself: What do these companies have in common? Not cultivation. Not greenhouses. Not production. Instead, they strengthened: 🟢 Customer access 🟢 E-commerce 🟢 Distribution 🟢 Procurement 🟢 Europe One acquisition after another follows the same direction. Whether that strategy ultimately succeeds remains to be seen. But it doesn't look random. It looks intentional. Next: Why procurement may become more valuable than cultivation. $HITI $MSOS $GTBIF $TRLV
0 · Reply
tutster
tutster Jun. 29 at 11:55 AM
$HITI The High Tide Research Series part one of many Most investors still value $HITI as a Canadian cannabis retailer. I think that's becoming an outdated way to look at the company. Today's High Tide is building several businesses simultaneously: 🟢 Canada's largest cannabis retail network by store count 🟢 Europe's fastest-growing medical cannabis distributor through Remexian 🟢 One of the industry's largest cannabis loyalty ecosystems 🟢 Procurement-first business model instead of cultivation 🟢 Growing White Label strategy 🟢 Global CBD & e-commerce ecosystem The question is no longer: "How many stores does High Tide own?" The better question is: "What business is High Tide becoming?" This series isn't about hype. It's about understanding the strategy Raj Grover has been building for years. Next: Why procurement may ultimately become more valuable than cultivation. $HITI $MSOS $GTBIF $TRLV $VRNO
0 · Reply
MOONEYMAN
MOONEYMAN Jun. 29 at 11:05 AM
0 · Reply
MOONEYMAN
MOONEYMAN Jun. 29 at 10:36 AM
$TRLV HEDGIE LET YOU POSTERS POST…
0 · Reply
diamondtouch
diamondtouch Jun. 29 at 4:07 AM
$MSOS $HITI $GTBIF $TRLV $CURLD Schedule I drugs are defined by the DEA as having no currently accepted medical use. Medical cannabis has now been classified as Schedule 3, which means it does have a currently accepted medical use. If cannabis has an accepted medical use, recreational cannabis no longer fits the definition of a Schedule I drug. Case closed.
4 · Reply
LifeBeGreat
LifeBeGreat Jun. 29 at 2:47 AM
$TRLV Yahoo Finance is highly prone to confusing, disconnected data bugs in the extended hours because of the specific way they source and structure their feeds. Professional platforms like Thinkorswim are much more reliable because they strictly route through institutional clearing networks.
0 · Reply
Latest News on TRLV
FAITH2026
FAITH2026 Jun. 29 at 3:29 PM
$TRLV You would think that with the ALJ Hearings starting today, that the Cannabis Sector would show some signs of life. Maybe the retail investor has just been burned way too many times before with "buy the rumor, sell the news".
2 · Reply
tutster
tutster Jun. 29 at 3:01 PM
$HITI Europe: More Than Just Germany Many investors still view Remexian as a German acquisition. I don't. Since acquiring Remexian, High Tide has: 🟢 Increased German medical cannabis market share from ~5% to ~14% 🟢 Successfully resolved major procurement challenges 🟢 Recovered gross margins to 27% 🟢 Secured exclusive supply agreements with leading Canadian LPs 🟢 Established itself as one of Germany's leading medical cannabis distributors Germany is already Europe's largest medical cannabis market. Management has repeatedly highlighted the UK as its next strategic opportunity, with independent forecasts projecting a medical cannabis market of ~£900M by 2030. France, Poland and other European markets are gradually opening as well. To me, High Tide didn't buy Germany. It bought a gateway into Europe. $HITI $MSOS $GTBIF $TRLV
0 · Reply
thepalace2007
thepalace2007 Jun. 29 at 1:57 PM
$TRLV this will be $20+ very soon
0 · Reply
tutster
tutster Jun. 29 at 12:32 PM
$HITI Procurement: The Most Overlooked Competitive Advantage? Most investors compare cannabis companies by: • Revenue • EBITDA • Store count But mature industries often reward something else. 🟢 Costco didn't become successful because it produced food. 🟢 Walmart doesn't manufacture consumer goods. 🟢 McKesson doesn't invent pharmaceuticals. They control purchasing power. The larger the purchasing volume... 🟢 the better the prices 🟢 the stronger the supplier relationships 🟢 the greater the product selection 🟢 the higher the potential margin Raj Grover rarely talks about becoming the largest grower. Instead, he repeatedly talks about procurement and building the largest cannabis menu. Could procurement become one of High Tide's biggest competitive advantages? Next: Why Europe could be much bigger than most investors expect. $HITI $MSOS $GTBIF $TRLV
2 · Reply
tutster
tutster Jun. 29 at 12:17 PM
$HITI Follow The Money One of the best ways to understand a company is to ignore what management says... ...and look at where they allocate capital. Over the past few years, Raj Grover acquired: 🟢 Smoke Cartel 🟢 Daily High Club 🟢 NuLeaf Naturals 🟢 FAB CBD 🟢 DankStop 🟢 Remexian Now ask yourself: What do these companies have in common? Not cultivation. Not greenhouses. Not production. Instead, they strengthened: 🟢 Customer access 🟢 E-commerce 🟢 Distribution 🟢 Procurement 🟢 Europe One acquisition after another follows the same direction. Whether that strategy ultimately succeeds remains to be seen. But it doesn't look random. It looks intentional. Next: Why procurement may become more valuable than cultivation. $HITI $MSOS $GTBIF $TRLV
0 · Reply
tutster
tutster Jun. 29 at 11:55 AM
$HITI The High Tide Research Series part one of many Most investors still value $HITI as a Canadian cannabis retailer. I think that's becoming an outdated way to look at the company. Today's High Tide is building several businesses simultaneously: 🟢 Canada's largest cannabis retail network by store count 🟢 Europe's fastest-growing medical cannabis distributor through Remexian 🟢 One of the industry's largest cannabis loyalty ecosystems 🟢 Procurement-first business model instead of cultivation 🟢 Growing White Label strategy 🟢 Global CBD & e-commerce ecosystem The question is no longer: "How many stores does High Tide own?" The better question is: "What business is High Tide becoming?" This series isn't about hype. It's about understanding the strategy Raj Grover has been building for years. Next: Why procurement may ultimately become more valuable than cultivation. $HITI $MSOS $GTBIF $TRLV $VRNO
0 · Reply
MOONEYMAN
MOONEYMAN Jun. 29 at 11:05 AM
0 · Reply
MOONEYMAN
MOONEYMAN Jun. 29 at 10:36 AM
$TRLV HEDGIE LET YOU POSTERS POST…
0 · Reply
diamondtouch
diamondtouch Jun. 29 at 4:07 AM
$MSOS $HITI $GTBIF $TRLV $CURLD Schedule I drugs are defined by the DEA as having no currently accepted medical use. Medical cannabis has now been classified as Schedule 3, which means it does have a currently accepted medical use. If cannabis has an accepted medical use, recreational cannabis no longer fits the definition of a Schedule I drug. Case closed.
4 · Reply
LifeBeGreat
LifeBeGreat Jun. 29 at 2:47 AM
$TRLV Yahoo Finance is highly prone to confusing, disconnected data bugs in the extended hours because of the specific way they source and structure their feeds. Professional platforms like Thinkorswim are much more reliable because they strictly route through institutional clearing networks.
0 · Reply
LifeBeGreat
LifeBeGreat Jun. 29 at 2:47 AM
$TRLV TRLV shares closed the regular trading session at $8.99, and subsequently shifted to $8.82 (a drop of $0.17, or -1.85%) in the after-hours market. The after-hours trading session recorded a volume of 31,45K shares.
0 · Reply
LordFawkwadReturns
LordFawkwadReturns Jun. 29 at 2:08 AM
$TRLV Hope you got some cheapies
1 · Reply
MinutemanIII
MinutemanIII Jun. 29 at 1:44 AM
$MSOS $TRLV is up 9%
1 · Reply
anarchist123
anarchist123 Jun. 29 at 12:53 AM
$TRLV overnight looking bigly.
0 · Reply
Zamboni18
Zamboni18 Jun. 28 at 11:16 PM
0 · Reply
MOONEYMAN
MOONEYMAN Jun. 28 at 2:01 PM
$TRLV 6/29/2026 MARK IT
0 · Reply
thepalace2007
thepalace2007 Jun. 28 at 1:02 PM
0 · Reply
HSR_Stocks
HSR_Stocks Jun. 28 at 12:17 PM
$TRLV $CURLD $GTBIF $MSOS good luck to us all going into this week. I’m really hoping we get positive reports tomorrow and Tuesday showing that the DEA is really pushing for rescheduling. The preliminary reports of what the witnesses are expected to testify to already seem very positive
3 · Reply
LifeBeGreat
LifeBeGreat Jun. 28 at 4:37 AM
$TRLV curaleaf is exactly a buck higher than Trulieve now...but only because they did a 1:3 reverse split on June 5th. If Trulieve did the same reverse split on June 5th sp would be around 35 bucks. That would have been interesting but crazy.
2 · Reply
Khalifha
Khalifha Jun. 27 at 9:57 PM
0 · Reply
WallStreetSignals
WallStreetSignals Jun. 27 at 7:21 PM
0 · Reply
rexwiggins
rexwiggins Jun. 27 at 5:15 PM
0 · Reply